These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Operational tolerance after intestine re-transplantation in childhood and immunological correlates. Case report and review. Remaley L; Ashokkumar C; Soltys KA; Mazariegos GV; Bond GJ; Khanna A; Ganoza A; Reyes-Mugica M; Zeevi A; Sindhi R Pediatr Transplant; 2023 May; 27(3):e14455. PubMed ID: 36529933 [TBL] [Abstract][Full Text] [Related]
3. Operational tolerance after pediatric composite liver-pancreas-intestine transplantation following severe graft-versus-host disease. Osborn J; Nathan JD; Tiao G; Alonso M; Kocoshis S Pediatr Transplant; 2021 Sep; 25(6):e14069. PubMed ID: 34125501 [TBL] [Abstract][Full Text] [Related]
4. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362 [TBL] [Abstract][Full Text] [Related]
5. The Fourth International Workshop on Clinical Transplant Tolerance. Issa F; Strober S; Leventhal JR; Kawai T; Kaufman DB; Levitsky J; Sykes M; Mas V; Wood KJ; Bridges N; Welniak LA; Chandran S; Madsen JC; Nickerson P; Demetris AJ; Lakkis FG; Thomson AW Am J Transplant; 2021 Jan; 21(1):21-31. PubMed ID: 32529725 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Shaked A; DesMarais MR; Kopetskie H; Feng S; Punch JD; Levitsky J; Reyes J; Klintmalm GB; Demetris AJ; Burrell BE; Priore A; Bridges ND; Sayre PH Am J Transplant; 2019 May; 19(5):1397-1409. PubMed ID: 30506630 [TBL] [Abstract][Full Text] [Related]
7. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Pirenne J; Koshiba T; Geboes K; Emonds MP; Ferdinande P; Hiele M; Nevens F; Waer M Transplantation; 2002 Mar; 73(6):966-8. PubMed ID: 11923701 [TBL] [Abstract][Full Text] [Related]
8. The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation. Ceulemans LJ; Braza F; Monbaliu D; Jochmans I; De Hertogh G; Du Plessis J; Emonds MP; Kitade H; Kawai M; Li Y; Zhao X; Koshiba T; Sprangers B; Brouard S; Waer M; Pirenne J Am J Transplant; 2016 Oct; 16(10):2973-2985. PubMed ID: 27037650 [TBL] [Abstract][Full Text] [Related]
11. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009). Cai J Clin Transpl; 2009; ():83-101. PubMed ID: 20524278 [TBL] [Abstract][Full Text] [Related]
12. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization. Sarwal MM Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635 [TBL] [Abstract][Full Text] [Related]
13. Approaching the promise of operational tolerance in clinical transplantation. Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029 [TBL] [Abstract][Full Text] [Related]